Stockreport

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

FibroBiologics, Inc.  (FBLG) 
PDF HOUSTON, Oct. 29, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 160+ patents issued and [Read more]